Experienced in Hypophosphatemia

Dr. Ravi A. Madan

Hematology Oncology
450 Massachusetts Ave Nw, #608, 
Washington, DC 
Experienced in Hypophosphatemia
450 Massachusetts Ave Nw, #608, 
Washington, DC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ravi Madan is a Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Madan is rated as an Experienced provider by MediFind in the treatment of Hypophosphatemia. His top areas of expertise are Prostate Cancer, Chordoma, Medullary Thyroid Carcinoma, Orchiectomy, and Prostatectomy.

His clinical research consists of co-authoring 190 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hypophosphatemia.

Specialties
Hematology Oncology
Licenses
Internal Medicine in NJ
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

450 Massachusetts Ave Nw, #608, Washington, DC 20001

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer
A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer
Enrollment Status: Completed
Publish Date: July 09, 2024
Intervention Type: Biological
Study Drug: GI-6207
Study Phase: Phase 2
A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of VT-464 in Patients With Metastatic Castration Resistant Prostate Cancer Who Have Previously Been Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancer
A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of VT-464 in Patients With Metastatic Castration Resistant Prostate Cancer Who Have Previously Been Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancer
Enrollment Status: Completed
Publish Date: May 07, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

189 Total Publications

A Deep Learning Model for Comprehensive Automated Bone Lesion Detection and Classification on Staging Computed Tomography Scans.
A Deep Learning Model for Comprehensive Automated Bone Lesion Detection and Classification on Staging Computed Tomography Scans.
Journal: Academic radiology
Published: May 07, 2025
Similar Doctors
Distinguished in Hypophosphatemia
Dr. Michael A. Auerbach
Hematology Oncology | Hematology | Oncology
Distinguished in Hypophosphatemia
Dr. Michael A. Auerbach
Hematology Oncology | Hematology | Oncology

Auerbach Hematology Oncology Associates P C

5233 King Ave, Suite 308, 
Baltimore, MD 
 (43.1 miles away)
410-780-4050
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Auerbach is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Auerbach is rated as a Distinguished provider by MediFind in the treatment of Hypophosphatemia. His top areas of expertise are Iron Deficiency Anemia, Anemia, Hypophosphatemia, and Childhood Iron Deficiency Anemia. Dr. Auerbach is currently accepting new patients.

Experienced in Hypophosphatemia
Dr. Gideon M. Blumenthal
Hematology Oncology
Experienced in Hypophosphatemia
Dr. Gideon M. Blumenthal
Hematology Oncology
8901 Wisconsin Ave, National Navy Medical Center Bldg. 8, Rm. 4152, 
Bethesda, MD 
 (7.9 miles away)
301-435-5868
Languages Spoken:
English

Gideon Blumenthal is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Blumenthal is rated as an Advanced provider by MediFind in the treatment of Hypophosphatemia. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Ruvalcaba Syndrome, Bannayan-Riley-Ruvalcaba Syndrome, and Tissue Biopsy.

Experienced in Hypophosphatemia
Dr. Richard Pazdur
Hematology Oncology
Experienced in Hypophosphatemia
Dr. Richard Pazdur
Hematology Oncology
10202 Addison Ct, 
Bethesda, MD 
 (10.3 miles away)
301-897-5828
Languages Spoken:
English

Richard Pazdur is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Pazdur is rated as an Advanced provider by MediFind in the treatment of Hypophosphatemia. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Breast Cancer, Tissue Biopsy, and Nephrectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Madan's expertise for a condition
ConditionClose
View All 15 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile